Biomedical engineers at Washington University in St. Louis have developed a technique using focused ultrasound and microbubbles to temporarily open the blood-brain barrier, enabling the delivery of immunotherapy drugs to treat brain cancer, as demonstrated in preclinical studies with large animal models.